HCMZX
Price
$20.11
Change
+$0.12 (+0.60%)
Updated
Jul 25 closing price
Net Assets
1.79B
RWIBX
Price
$71.31
Change
+$0.04 (+0.06%)
Updated
Jul 25 closing price
Net Assets
137.34B
Interact to see
Advertisement

HCMZX vs RWIBX

Header iconHCMZX vs RWIBX Comparison
Open Charts HCMZX vs RWIBXBanner chart's image
HCM Sector Plus R
Price$20.11
Change+$0.12 (+0.60%)
VolumeN/A
Net Assets1.79B
American Funds Capital World Gr&Inc R2
Price$71.31
Change+$0.04 (+0.06%)
VolumeN/A
Net Assets137.34B
HCMZX vs RWIBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HCMZX vs. RWIBX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCMZX is a StrongBuy and RWIBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 137B vs. HCMZX (1.79B). RWIBX pays higher dividends than HCMZX: RWIBX (0.82) vs HCMZX (0.00). HCMZX was incepted earlier than RWIBX: HCMZX (10 years) vs RWIBX (23 years). HCMZX (2.36) is less costly to investors than RWIBX (1.51). HCMZX is a more actively managed with annual turnover of: 108.00 vs. RWIBX (27.00). HCMZX has a lower initial minimum investment than RWIBX: HCMZX (0) vs RWIBX (250). RWIBX annual gain was more profitable for investors over the last year : 12.86 vs. HCMZX (-0.94). HCMZX return over 5 years is better than : 60.86 vs. RWIBX (47.06).
HCMZXRWIBXHCMZX / RWIBX
Total Expense Ratio1.861.51123%
Annual Report Gross Expense Ratio2.361.51156%
Fund Existence10 years23 years-
Gain YTD6.23314.52543%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.79B137B1%
Annual Yield % from dividends0.000.82-
Returns for 1 year-0.9412.86-7%
Returns for 3 years15.7648.0333%
Returns for 5 years60.8647.06129%
Returns for 10 years113.1958.36194%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMCB0.95N/A
+0.53%
PharmaCyte Biotech
INTA41.640.12
+0.29%
Intapp
DDI9.67-0.03
-0.31%
DoubleDown Interactive Co Ltd
XP16.56-0.09
-0.54%
XP
PIII7.27-0.13
-1.76%
P3 Health Partners Inc